City

Boston (1)

Leicester (1)

Lille (1)

Lyon (1)

Condition

Lymphoma, Diffuse (2)

Lymphoma, B-Cell (1)

Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic (1)

Lymphoma, Non-Hodgkin (1)

Non-Hodgkin's Lymphoma (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Gilead Sciences (1)

Massachusetts General Hospital (1)

Collaborator

Bayer (1)

Beth Israel Deaconess Medical Center (1)

Brigham and Women's Hospital (1)

Dana-Farber Cancer Institute (1)

Intervention

chop (1)

gm-csf (1)

rituximab (1)

veltuzumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

lymphoma, diffuse

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Non-Hodgkin's Lymphoma, Lymphoma, Diffuse, Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Trial in Lille, Lyon, Leicester

Completed

Non-Hodgkin's Lymphoma
+2 more

veltuzumab

Lille, Cedex, France
+2 more

Aug 12, 2021

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Diffuse Trial in Boston (GM-CSF, CHOP, Rituximab)

Terminated

Lymphoma, Non-Hodgkin
+2 more

GM-CSF
+2 more

Boston, Massachusetts
+2 more

Jan 16, 2018